Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cytoclonal Pharmaceutics INC. -- Ignore unavailable to you. Want to Upgrade?

To: JOHN ASHBOLT who wrote (2)	9/7/1999 11:28:00 PM
From: Maurice Winn	Read Replies (1) \| Respond to of 6

Gee John, that's interesting Cytoclonal recently purchased a novel computed aided technology for designing new drugs called Quantum Core Technology QCT. QCT was developed by Dr Dorit Arid, previously of Tel Aviv University. He has moved to Dallas and joined CYPH as Vice President of drug design. Speak of the devil! That should speed up the process a billion-fold. Trees take too long to invent a new chemistry and they might miss some options since they are specifically trying to kill us, not help us. Do you have a url for Cytoclonal Pharmaceuticals web site please? Maurice